Anti-Demodex wipes development

抗蠕形螨湿巾的开发

• 批准号: 562193-2021
• 负责人: Rogers, Ben
• 金额: $ 1.82万
• 依托单位: Seneca College of Applied Arts and Technology
• 依托单位国家: 加拿大
• 项目类别: Applied Research and Development Grants - Level 1
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=724604
• 关键词: Anti; Demodex; wipes; development

I-MED Pharma Inc. (I-MED) provides innovative ocular surface disease (OSD) solutions to the globaloptometry and ophthalmology community-based care sectors. With a focus on research, I-MED Pharma'svision is to be the leading dry eye and OSD company in the world. Currently, they offer a complete range ofOSD products, including diagnostic tools, artificial tears, ocular hygiene cleansers, and therapeutic accessories.The Demodex mite, which can cause Dry Eye Disease and other ailments, can be maintained at a harmlesslevel using some natural products. However, current products have been shown in vitro to have potentiallyharmful effects on eye glands. I-MED Pharma will collaborate with Seneca's School of Biological Sciences andApplied Chemistry to develop an eye wipe formulation with an active ingredient that limits proliferation ofDemodex mites without irritating the eye and eye-physiology. Led by Professors Sonal Kamath and SharonRobertson, student Research Assistants (RAs) from Seneca's Cosmetic Sciences Graduate Certificate programwill apply their academic knowledge and skills, while developing practical experience in formulation andevaluating product efficacy, to create a prototype formulation of a TTO-free wipe designed to be effectiveagainst Demodex mites that does not cause irritation to the eye. This new formulation will reinforce I-MED'sposition in the global market as a leader in dry eye care and eye hygiene.

I-MED Pharma Inc.（I-MED）为全球验光和眼科社区护理行业提供创新的眼表疾病（OSD）解决方案。I-MED Pharma的愿景是成为全球领先的干眼和OSD公司。目前，他们提供了一个完整的OSD产品系列，包括诊断工具，人工泪液，眼部卫生清洁剂，和治疗配件。蠕形螨，可导致干眼病和其他疾病，可以保持在一个无害的水平，使用一些天然产品。然而，目前的产品已经在体外被证明对眼腺有潜在的有害影响。I-MED Pharma将与Seneca的生物科学和应用化学学院合作，开发一种含有活性成分的擦眼配方，该配方可以限制蠕形螨的增殖，而不会刺激眼睛和眼睛生理。在Sonal Kamath教授和SharonRobertson教授的带领下，Seneca化妆品科学研究生证书课程的学生研究助理（RA）将运用他们的学术知识和技能，同时发展配方和评估产品功效的实践经验，以创建一种无TTO擦拭物的原型配方，该配方旨在有效对抗蠕形螨，不会对眼睛造成刺激。这一新配方将巩固I-MED在全球干眼症护理和眼部卫生领域的领导地位。